chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride and clidinium bromide
Labeler: a-s medication solutionsDrug Facts
Product Profile
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide
Labeler
a-s medication solutions
Dosage Form
CAPSULE
Routes
Active Ingredients
chlordiazepoxide hydrochloride 5 mg/1, clidinium bromide 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50090-6310
Product ID
50090-6310_44a52833-81d0-4b4a-8f7b-e863b94af466
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214698
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2021-05-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
500906310
Hyphenated Format
50090-6310
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Application Number
ANDA214698 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 2.5 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (50090-6310-0)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "44a52833-81d0-4b4a-8f7b-e863b94af466", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["883efb7c-7ab2-434b-9094-5a620375b6d2"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-6310-0)", "package_ndc": "50090-6310-0", "marketing_start_date": "20230103"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "50090-6310_44a52833-81d0-4b4a-8f7b-e863b94af466", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "50090-6310", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA214698", "marketing_category": "ANDA", "marketing_start_date": "20210510", "listing_expiration_date": "20261231"}